Penn study uncovers possible COVID-19 drugs—including several that are already FDA-approved
A team led by scientists in the Perelman School has identified nine potential new COVID-19 treatments, including three that are already approved by the Food and Drug Administration (FDA) for treating other diseases. The team screened thousands of existing drugs and drug-like molecules for their ability to inhibit the replication of the COVID-19-causing coronavirus, SARS-CoV-2.
FULL STORY AT Penn Medicine News →